D. E. Shaw & Co., Inc.
Position in DMAA — Drugs Made In America Acquisition Corp.
CIK 1009207
New York, NY
Position in DMAA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,231,200
+$73,140 QoQ
Shares Held
690,000
0.0% QoQ
Ownership
2.84%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 39 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DMAA Over Time
Shares Held
Position Value (USD)
Position in Shell Companies
Financial Services · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $965,870,837 across 149 Shell Companies names. DMAA ranks #58 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CEPF |
Cantor Equity Partners IV, Inc.
|
1,831,856 | $18,666,612 | |
| 2 | GPAT |
GP-Act III Acquisition Corp.
|
1,423,125 | $15,426,675 | |
| 3 | KFII |
K&F Growth Acquisition Corp. II
|
1,422,909 | $14,840,940 | |
| 4 | EVAC |
EQV Ventures Acquisition Corp. II
|
1,460,600 | $14,737,454 | |
| 5 | ALF |
Centurion Acquisition Corp.
|
1,309,906 | $14,094,588 | |
| 6 | BCAR |
D. Boral ARC Acquisition I Corp.
|
1,385,950 | $14,025,814 | |
| 7 | TACH |
Titan Acquisition Corp.
|
1,353,849 | $13,931,106 | |
| 8 | DMII |
Drugs Made In America Acquisition II Corp.
|
1,390,100 | $13,859,297 |
All Filings in DMAA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,231,200 | 690,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,158,060 | 690,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,086,300 | 690,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,038,000 | 690,000 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||